obesity-995x60.png
FEATURED ARTICLES
What ClinOps Gets Wrong About Pediatric Trials
Pediatric cancer advocates Brian Burkhardt and Andy Shepperd believe clinical research still confuses retention with relationships. Their lessons on trust, community, and patient support offer valuable insights for clinical operations teams across every therapeutic area.
-
How The Quiet Data Standards Revolution Is Impacting Drug Approval
Principal Statistical Programmer Varun Debbeti details the role data standards play in approval timelines, detailing shortfalls of current the model and CORE, Dataset-JSON, and SDTM v3.0 stand to make an impact.
-
How Pharmacometrics Informs Dose Selection And Biomarker Decisions
Quantitative modeling informs dose selection and biomarker insights early, reducing uncertainty, improving study design, and enabling faster, more confident decisions from first trials to clinical progress.
-
Designing Trials For Disease Modification: Cereno Scientific's Approach To Pulmonary Arterial Hypertension
Cereno Scientific’s Rahul Agrawal discusses the scientific and strategic rationale behind extending the company’s Phase 2b study duration and how the company incorporated regulator and patient input.